Lupus Activity in Pregnancy

Rheumatic Disease Clinics of North America

Volumn 33, Issue 2, 2007, Pages 237-252

  Clowse, Megan E B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 METHYLTHIOINOSINE; ANTIMALARIAL AGENT; AZATHIOPRINE; BETAMETHASONE; C REACTIVE PROTEIN; COMPLEMENT; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DNA ANTIBODY; ESTROGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FOLIC ACID; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LEFLUNOMIDE; METHOTREXATE; MULTIVITAMIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACENTAL GROWTH FACTOR; PREDNISOLONE; PREDNISONE; PROSTAGLANDIN SYNTHASE; RELAXIN; STEROID;

CESAREAN SECTION; COMPLEMENT BLOOD LEVEL; CONTRACEPTION; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FETUS MALFORMATION; FETUS WASTAGE; FIBROMYALGIA; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; LOW BIRTH WEIGHT; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROLONGED PREGNANCY; REVIEW; RISK ASSESSMENT; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; STILLBIRTH; SURVIVAL RATE; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN SUPPLEMENTATION;

ADULT; ANIMALS; AZATHIOPRINE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREMATURE BIRTH;

EID: 34248176839     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.01.002     Document Type: Review

References (64)

1. Clowse M.E.B., Jamison M.G., Myers E., et al. National study of medical complications in SLE pregnancies. Arthritis Rheum 54 9 Suppl (2006) S263-S264
2. Chakravarty E.F., Nelson L., and Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 54 3 (2006) 899-907
3. Clark C.A., Spitzer K.A., Nadler J.N., et al. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol 30 10 (2003) 2127-2132
4. Cohen-Solal J.F., Jeganathan V., Grimaldi C.M., et al. Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr Top Microbiol Immunol 305 (2006) 67-88
5. Grimaldi C.M. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Curr Opin Rheumatol 18 5 (2006) 456-461
6. Lockshin M.D. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 32 6 (1989) 665-670
7. Meehan R.T., and Dorsey J.K. Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol 14 2 (1987) 252-258
8. Urowitz M.B., Gladman D.D., Farewell V.T., et al. Lupus and pregnancy studies. Arthritis Rheum 36 10 (1993) 1392-1397
9. Tincani A., Faden D., Tarantini M., et al. Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol 10 5 (1992) 439-446
10. Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum Dis Clin North Am 23 1 (1997) 1-13
11. Lima F., Buchanan N.M., Khamashta M.A., et al. Obstetric outcome in systemic lupus erythematosus. Semin Arthritis Rheum 25 3 (1995) 184-192
12. Carmona F., Font J., Cervera R., et al. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 83 2 (1999) 137-142
13. Cortes-Hernandez J., Ordi-Ros J., Paredes F., et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 41 6 (2002) 643-650
14. Chakravarty E.F., Colon I., Langen E.S., et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 192 6 (2005) 1897-1904
15. Rubbert A., Pirner K., Wildt L., et al. Pregnancy course and complications in patients with systemic lupus erythematosus. Am J Reprod Immunol 28 3-4 (1992) 205-207
16. Clowse M.E., Magder L.S., Witter F., et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52 2 (2005) 514-521
17. Clowse M.E., Magder L., Witter F., et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54 11 (2006) 3640-3647
18. Georgiou P.E., Politi E.N., Katsimbri P., et al. Outcome of lupus pregnancy: a controlled study. Rheumatology (Oxford) 39 9 (2000) 1014-1019
19. Petri M., Howard D., Repke J., et al. The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am J Reprod Immunol 28 3-4 (1992) 188-191
20. Wong K.L., Chan F.Y., and Lee C.P. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med 151 2 (1991) 269-273
21. Clowse M.E., Magder L.S., Witter F., et al. Early risk factors for pregnancy loss in lupus. Obstet Gynecol 107 2 Pt 1 (2006) 293-299
22. Yasmeen S., Wilkins E.E., Field N.T., et al. Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med 10 2 (2001) 91-96
23. Johnson M.J., Petri M., Witter F.R., et al. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol 86 3 (1995) 396-399
24. Magid M.S., Kaplan C., Sammaritano L.R., et al. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 179 1 (1998) 226-234
25. Alexander G.R., Himes J.H., Kaufman R.B., et al. A United States national reference for fetal growth. Obstet Gynecol 87 2 (1996) 163-168
26. Moroni G., and Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J Nephrol 16 2 (2003) 161-167
27. Qazi U.M., and Petri M. Autoantibodies, low complement, and obesity predict preeclampsia in SLE: a case-control study. Arthritis Rheum 54 9 Suppl (2006) S264
28. Qazi U.M., Lam C., Karumanchi A., et al. Soluble FMS-like tyrosine kinase is a significant predictor of preeclampsia in SLE pregnancy. Arthritis Rheum 54 9 Suppl (2006) S264-S265
29. Julkunen H., Kaaja R., Palosuo T., et al. Pregnancy in lupus nephropathy. Acta Obstet Gynecol Scand 72 4 (1993) 258-263
30. Huong D.L., Wechsler B., Vauthier-Brouzes D., et al. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis 60 6 (2001) 599-604
31. Moroni G., Quaglini S., Banfi G., et al. Pregnancy in lupus nephritis. Am J Kidney Dis 40 4 (2002) 713-720
32. Jungers P., Dougados M., Pelissier C., et al. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med 142 4 (1982) 771-776
33. Oviasu E., Hicks J., and Cameron J.S. The outcome of pregnancy in women with lupus nephritis. Lupus 1 1 (1991) 19-25
34. Buyon J.P., Kalunian K.C., Ramsey-Goldman R., et al. Assessing disease activity in SLE patients during pregnancy. Lupus 8 8 (1999) 677-684
35. De Man Y.A., Hazes J.M.W., Van de Geijn F.E., et al. How to measure functionality and disease activity during pregnancy in rheumatoid arthritis patients. Ann Rheum Dis 64 Suppl III (2005) 196
36. Ostensen M., Rugelsjoen A., and Wigers S.H. The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol 26 5 (1997) 355-360
37. Ho A., Barr S.G., Magder L.S., et al. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Arthritis Rheum 44 10 (2001) 2350-2357
38. Buyon J.P., Tamerius J., Ordorica S., et al. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy. Arthritis Rheum 35 1 (1992) 55-61
39. Clowse M.E.B., Magder L.S., and Petri M. Complement and double-stranded DNA antibodies predict pregnancy outcomes in lupus patients. Arthritis Rheum 50 9 Suppl (2004) S408
40. Pitiphat W., Gillman M.W., Joshipura K.J., et al. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 162 11 (2005) 1108-1113
41. Hesselink D.A., Aarden L.A., and Swaak A.J. Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus. Scand J Rheumatol 32 3 (2003) 151-155
42. Williams Jr. R.C., Harmon M.E., Burlingame R., et al. Studies of serum C-reactive protein in systemic lupus erythematosus. J Rheumatol 32 3 (2005) 454-461
43. ter Borg E.J., Horst G., Limburg P.C., et al. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 17 12 (1990) 1642-1648
44. Kasitanon N., Fine D.M., Haas M., et al. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis. Lupus 15 6 (2006) 366-370
45. Alarcon G.S., McGwin Jr. G., Bastian H.M., et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 45 2 (2001) 191-202
46. The Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 324 3 (1991) 150-154
47. Ostensen M., Khamashta M., Lockshin M., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8 3 (2006) 209-228
48. Costedoat-Chalumeau N., Amoura Z., Duhaut P., et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 48 11 (2003) 3207-3211
49. de Boer N.K., Jarbandhan S.V., de Graaf P., et al. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol 101 6 (2006) 1390-1392
50. Davison J.M., Dellagrammatikas H., and Parkin J.M. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 92 3 (1985) 233-239
51. Miniero R., Tardivo I., Curtoni E.S., et al. Pregnancy after renal transplantation in Italian patients: focus on fetal outcome. J Nephrol 15 6 (2002) 626-632
52. Clowse M.E.B., Magder L.S., Witter F., et al. Azathioprine use in lupus pregnancy. Arthritis Rheum 52 9 Suppl (2005) S386-S387
53. Canfield M.A., Honein M.A., Yuskiv N., et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 76 11 (2006) 747-756
54. Pradat P., Robert-Gnansia E., Di Tanna G.L., et al. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol 67 12 (2003) 968-970
55. Scherle P.A., Ma W., Lim H., et al. Regulation of cyclooxygenase-2 induction in the mouse uterus during decidualization. An event of early pregnancy. J Biol Chem 275 47 (2000) 37086-37092
56. Li D.K., Liu L., and Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 327 7411 (2003) 368-378
57. Topuz S., Has R., Ermis H., et al. Acute severe reversible oligohydramnios induced by indomethacin in a patient with rheumatoid arthritis: a case report and review of the literature. Clin Exp Obstet Gynecol 31 1 (2004) 70-72
58. Holmes R.P., and Stone P.R. Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide. Obstet Gynecol 96 5 Pt 2 (2000) 810-811
59. Whitelaw A., and Thoresen M. Antenatal steroids and the developing brain. Arch Dis Child Fetal Neonatal Ed 83 2 (2000) F154-F157
60. Costedoat-Chalumeau N., Amoura Z., Le Thi Hong D., et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 62 10 (2003) 1010-1012
61. Zandman-Goddard G., Levy Y., and Shoenfeld Y. Intravenous immunoglobulin therapy and systemic lupus erythematosus. Clin Rev Allergy Immunol 29 3 (2005) 219-228
62. Rauova L., Lukac J., Levy Y., et al. High-dose intravenous immunoglobulins for lupus nephritis-a salvage immunomodulation. Lupus 10 3 (2001) 209-213
63. Clowse M.E., Magder L., and Petri M. Cyclophosphamide for lupus during pregnancy. Lupus 14 8 (2005) 593-597
64. Kart Koseoglu H., Yucel A.E., Kunefeci G., et al. Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy. Lupus 10 11 (2001) 818-820